Search

A recent study from the University Hospital Center in Lisbon, Portugal, highlights the importance of addressing coronary and structural heart disease in cancer patients. While there has been increased awareness of cardiotoxicity in cancer patients, the focus has primarily been on myocardial systolic dysfunction and heart failure. Limited evidence and guidelines exist for dealing with coronary and structural heart disease in this population. To address this gap, the Portuguese Association of Cardiovascular Intervention and the Cardio-Oncology Study Group of the Portuguese Society of Cardiology have collaborated to produce a position paper on cardiac intervention in cancer patients, with a focus on percutaneous techniques. The paper provides a brief review of available evidence and practical considerations based on the authors' experience in the field. [Extracted from the article]

For more information on this research see: Comparison of the Different Imaging Modalities Used To Image Pediatric Oncology Patients: a Cog Diagnostic Imaging Committee/spr Oncology Committee White Paper. Keywords: Durham; State:North Carolina; United States; North and Central America; Diagnostic Imaging; Diagnostics and Screening; Health and Medicine; Oncology; Pediatric Oncology; Pediatrics EN Durham State:North Carolina United States North and Central America Diagnostic Imaging Diagnostics and Screening Health and Medicine Oncology Pediatric Oncology Pediatrics 1034 1034 1 05/08/23 20230512 NES 230512 2023 MAY 9 (NewsRx) -- By a News Reporter-Staff News Editor at Pediatrics Week -- Investigators discuss new findings in Oncology - Pediatric Oncology. [Extracted from the article]

Keywords: Breast Cancer; Cancer; Circadian Rhythms; Drugs and Therapies; Health and Medicine; Oncology; Women's Health EN Breast Cancer Cancer Circadian Rhythms Drugs and Therapies Health and Medicine Oncology Women's Health 539 539 1 06/12/23 20230616 NES 230616 2023 JUN 13 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- New research on breast cancer is the subject of a new report. Breast Cancer, Cancer, Circadian Rhythms, Drugs and Therapies, Health and Medicine, Oncology, Women's Health. [Extracted from the article]

A study conducted by researchers at the Dana-Farber Cancer Institute in Boston, Massachusetts aimed to determine the best method for obtaining sensitive information from young adult cancer survivors (YACS). The study compared two methods of item administration, paper surveys and telephone automated computer-assisted structured interviews (TACASI), to assess the acceptability of asking about sensitive topics such as suicidal ideation and sexual health. The results showed that the proportion of participants reporting symptoms did not significantly vary between the two methods, and the majority of participants felt comfortable answering sensitive items regardless of the administration mode. The study suggests that screening for these sensitive topics can be integrated into clinical care for YACS using either paper or technology-assisted methods. [Extracted from the article]

This article discusses the research conducted on Helicobacter pylori infection and its link to gastric cancer. The researchers aimed to provide an update on the recent developments in this field. They conducted a search on the PubMed database for papers published in 2024 that met their inclusion criteria. The research found that there is a need for more studies on the immunopathology of H. pylori infection. The authors suggest that priority should be given to this type of research. [Extracted from the article]

Researchers at the University of Turku in Finland conducted an integrative review to identify personal health-related resources for women with breast cancer. The review analyzed 23 peer-reviewed scientific papers published between January 2005 and May 2021. The researchers found that personal health-related resources for women with breast cancer can be categorized into three interconnected categories: personal strengths, person-centered cancer care, and social support from and involvement in their cultural community. The study concludes that nursing support is necessary to help women identify and utilize these resources, and further research is needed to improve measurement methods. [Extracted from the article]

A research paper titled "Prevalence and spectrum of germline BRCA1 and BRCA2 in a cohort of ovarian cancer patients from the Salento peninsula (Southern Italy): a matter of preventive health" was recently published in Oncotarget. The study aimed to characterize the BRCA1 and BRCA2 variants in a group of ovarian cancer patients from the Salento peninsula. The researchers found that the prevalence of germline mutations in the BRCA1 and BRCA2 genes was higher than reported in other studies. This study provides valuable insights into the role of BRCA mutations in ovarian cancer treatment and prevention. [Extracted from the article]

A study published in JACC: CardioOncology has found that air pollution is a significant factor in increasing cardiovascular disease and mortality in cancer patients. The research highlights the need to consider environmental factors, particularly air pollution, in assessing the risk and managing the health of cardio-oncology patients. Exposure to fine particulates in the air, known as PM2.5, was found to be associated with higher rates of cardiovascular disease incidence and mortality among cancer patients. The study also emphasizes how air pollution contributes to health disparities, with disadvantaged populations and cancer patients of lower socioeconomic status facing a higher risk of cardiovascular disease mortality linked to air pollution. Further research is needed to understand the impacts of air pollution on cardiovascular disease and cancer in more detail and to develop tailored exposure control measures and patient management strategies. [Extracted from the article]

A recent report from Hasanuddin University discusses the assessment of the quality of life (QOL) for breast cancer patients undergoing chemotherapy. The researchers conducted a systematic review of 300 studies using various online databases and selected 20 papers that met their criteria. The study emphasizes the importance of using instruments to measure the QOL of breast cancer patients in order to understand the impact of the disease on their physical, mental, and social well-being. The full article can be accessed for free through the provided link. [Extracted from the article]

A recent study published in JAMA Network Open by an international group of researchers examines the effectiveness of chemotherapy, with or without radiation therapy, before surgery for pancreatic cancer patients. The study focuses on pancreatic adenocarcinoma patients and found that nearly five percent of patients achieved a pathological complete response (pCR), meaning no detectable cancer cells were left in the area where the tumor was. Patients with pCR had a 5-year survival rate of 63 percent, compared to 30 percent for those without pCR. The study also explores factors that contribute to pCR and suggests tailoring treatment based on these factors could be beneficial. However, further research is needed to validate these findings and understand their broader applicability. [Extracted from the article]

A research paper published in Oncotarget's Volume 14 on October 4, 2023, titled "Determination of genetic predisposition to early breast cancer in women of Kazakh ethnicity," explores the genetic factors associated with early-onset breast cancer in Kazakh women. Breast cancer is the most common type of cancer among women in Kazakhstan, but little data is available on the genetic variation in Kazakh women with breast cancer. The study used next-generation sequencing technology to identify population-specific genetic markers associated with the risk of developing early-onset breast cancer and their impact on clinical outcomes. The researchers identified 38 unique pathogenic variants in 13 different cancer-predisposing genes among the participants, including some novel variants. The study provides a foundation for developing regional expertise and diagnostic tools for early detection of breast cancer in young Kazakh women. [Extracted from the article]

A recent study conducted by researchers at the Vellore Institute of Technology in India has utilized artificial intelligence (AI) to predict mortality rates in head and neck cancer patients. The study found that lifestyle factors such as smoking and tobacco use are strongly associated with the development of cancerous cells in these regions of the body. By using machine learning and deep learning models, the researchers achieved a maximum accuracy of 98.8% in predicting mortality rates. The findings of this study have the potential to greatly impact medical professionals by aiding in the prediction of patient mortality and informing appropriate treatment strategies. [Extracted from the article]

Keywords: Cancer; Health and Medicine; Oncology EN Cancer Health and Medicine Oncology 1659 1659 1 11/06/23 20231107 NES 231107 2023 NOV 7 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Researchers detail new data in cancer. According to news originating from Mumbai, India, by NewsRx correspondents, research stated, "Cultural health attributions, beliefs, and perceptions towards health and illness influence the health-seeking behaviour and practices of cancer patients.". [Extracted from the article]

A recent report from the College of Nursing in Hangzhou, China, highlights the need for further research on advance care planning (ACP) for surrogate decision makers of advanced cancer patients. The study conducted a mixed-methods systematic review, analyzing 11 papers to identify influencing factors of ACP participation. The research found that public perception, communication, policies, and personal characteristics of surrogate decision makers can impact their ACP participation. The study suggests that education, effective communication mechanisms, and improved policies and regulations are needed to strengthen guidance and intervention in this area. [Extracted from the article]

A systematic review conducted by researchers at the University of Sussex in Brighton, United Kingdom, aimed to understand the risk factors associated with depression and anxiety in cancer patients. The study analyzed 21 eligible papers and identified 32 risk factors clustered into four domains: cancer-specific, biological, psychological, and social. The findings suggest the need for personalized psychological care in cancer treatment and highlight the importance of risk stratification in primary care. The research was supported by the National Institute for Health and Care Research. [Extracted from the article]

Researchers at Maastricht University in the Netherlands have conducted a systematic review on the relationship between affective symptoms and oropharyngeal dysphagia (OD) in head-and-neck cancer (HNC) patients. The review included 15 studies and found that there is a positive relationship between affective symptoms and OD in HNC patients. The researchers recommend early detection and an integrated interdisciplinary approach to address these symptoms. However, the generalization of study results is limited due to the heterogeneity of study designs, outcomes, and outcome measures. [Extracted from the article]

A recent integrative review conducted by researchers at Queen's University in Belfast, United Kingdom, explored the holistic needs of individuals living with cancer in care homes. The review identified three primary themes related to the holistic needs of care home residents with cancer: physical, psychological, and end-of-life needs. Physical needs included pain management, symptom control, and nutrition, while psychological needs involved social support, emotional well-being, and mental health care. End-of-life needs addressed end-of-life care and advance care planning. The study emphasizes the importance of addressing the diverse needs of residents with cancer in a comprehensive and integrated manner, including improving care home education about cancer and integrating palliative and hospice services within care home settings. [Extracted from the article]

In this article, the author shares her experience of suffering with cancer and undergoing various scan; and also discusses the state of the mind of cancer patients being one of them.

Prostate cancer study offers guidance on which patients most likely to benefit from treatment intensification Radiation therapy and long-term androgen deprivation therapy (RT+ltADT) is standard of care treatment for patients with high-risk, locally advanced prostate cancer (HR/LA-PC). Keywords: Antibodies; Bladder Cancer; Blood Proteins; Cancer; Carcinomas; Clinical Research; Clinical Trials and Studies; Dana-Farber Cancer Institute; Drug Conjugates; Drug Development; Drugs and Therapies; Genetics; Health and Medicine; Immunoglobulins; Immunology; Neuroendocrine Cancer; Neuroendocrine Tumors; Oncology; Personalized Medicine; Personalized Therapy; Prostate Cancer; Prostatic Neoplasms; Proteins; Risk and Prevention EN Antibodies Bladder Cancer Blood Proteins Cancer Carcinomas Clinical Research Clinical Trials and Studies Dana-Farber Cancer Institute Drug Conjugates Drug Development Drugs and Therapies Genetics Health and Medicine Immunoglobulins Immunology Neuroendocrine Cancer Neuroendocrine Tumors Oncology Personalized Medicine Personalized Therapy Prostate Cancer Prostatic Neoplasms Proteins Risk and Prevention 587 587 1 10/30/23 20231031 NES 231031 2023 OCT 31 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Farber oral abstracts is available here. [Extracted from the article]

The article focuses on a study which shows an improvement in the overall survival (OS) among patients with de novo metastatic hormone-sensitive prostate cancer in clinical practice in the U.S. from 2000 to 2019, which references a research paper by Martin Schoen et al., published in an issue of the "JAMA Network Open." Topics discussed include the median OS in patients younger than 70 years, and the significant role of combination therapy in this improvement.

Keywords: Breast Cancer; Cancer; Chemotherapy; Diet and Nutrition; Drugs and Therapies; Health and Medicine; Oncology; Vitamin D; Vitamins; Women's Health EN Breast Cancer Cancer Chemotherapy Diet and Nutrition Drugs and Therapies Health and Medicine Oncology Vitamin D Vitamins Women's Health 725 725 1 09/25/23 20230926 NES 230926 2023 SEP 26 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Data detailed on breast cancer have been presented. This paper aims to evaluate the changes in VD metabolites during chemotherapy (CTH) and the predictive role of VD status in Caucasian BC patients treated with CTH.". [Extracted from the article]

The 2022 China Breast Cancer Follow-up and Health Management Guidelines highlighted the number of approximately 420,000 new breast cancer diagnoses in China in 2022, which ranked first and represented almost 20% of all malignant tumors diagnosed in women in China. Keywords: Asia; Breast Cancer; Business; Cancer; China; Health and Medicine; Investment and Finance; Oncology; Quality of Life; Women's Health; Zhongchao Inc EN Asia Breast Cancer Business Cancer China Health and Medicine Investment and Finance Oncology Quality of Life Women's Health Zhongchao Inc 1472 1472 1 09/04/23 20230905 NES 230905 2023 SEP 5 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, announced it has achieved a milestone of serving over 10,000 breast cancer patients in China with comprehensive disease management services since 2021. The 2022 China Breast Cancer Patient Quality of Life White Paper sheds light on the economic strains: breast cancer patients are burdened with an average treatment expense of RMB206,000, with out-of-pocket costs reaching up to RBM111,000 based on the questionnaires completed by breast cancer patients. [Extracted from the article]

A new report from George Washington University discusses the importance of addressing the psychosocial needs of young adult cancer survivors. The report highlights the limited research in this area and the need for interventions that focus on positive outcomes like well-being. The researchers have developed an 8-week digital, coach-assisted intervention targeting hope among young adult cancer survivors and have outlined the protocol for a randomized controlled trial. The study aims to increase the sample size and utilize diversified recruitment efforts to enhance the intervention's reach and scalability. The outcomes of the trial will assess feasibility, acceptability, and preliminary efficacy on hope and quality of life measures. The report concludes by emphasizing the significance of addressing the psychosocial challenges faced by young adult survivors and the potential impact of the trial results. [Extracted from the article]

A report from Guangzhou University of Chinese Medicine discusses the rare postoperative complication of chyle leakage in breast cancer patients. The research emphasizes the importance of conservative treatments and careful monitoring of drainage volume, with surgical intervention as a last resort. The study highlights the lack of consensus in the literature regarding the management of chyle leaks after breast cancer surgery. The case report presented in the research demonstrates successful treatment with conservative measures and explores the various management options available to clinicians. For more information, the full article can be accessed through Wiley's Clinical Case Reports journal. [Extracted from the article]

A new study published in the Journal of the National Cancer Institute reveals significant disparities in the risk of anal cancer for people with HIV and men who have sex with men with HIV, depending on the region of the country they live in. The study shows that people with HIV have a higher relative risk of anal cancer compared to those without HIV, but the risk varies across the country. The study also suggests that opportunistic illnesses and co-morbidities, such as diabetes and cardiovascular disease, may be associated with the development of anal cancer in people with HIV. The findings highlight the need for further research into the causes of these disparities and the development of screening guidelines for anal cancer. [Extracted from the article]

A study on organs-on-a-chip technology in cancer patients has been conducted by researchers from the Department of Bioengineering. The study highlights the use of patient-derived organoids (PDOs) as a more physiologically relevant model for drug discovery and development compared to traditional cell lines. The researchers discuss recent advancements in PDO development and culture enhancement through materials engineering, including organs-on-a-chip technology. They also explore the challenges and future perspectives of using PDOs in drug development and personalized screening for cancer patients. The study was supported by various organizations, including the NIH National Cancer Institute and the Terasaki Institute for Biomedical Innovation. [Extracted from the article]

Objective. To evaluate, using semiparametric methodologies of survival analysis, the relationship between covariates and time to death of patients with breast cancer, as well as the determination discriminatory power in the conditional inference tree of patients who had cancer. Methods. A retrospective cohort study was conducted using data collected from medical records of women who had breast cancer and underwent treatment between 2005 and 2015 at the Hospital da Fundação de Assistencial da Paraíba in Campina Grande, State of Paraiba, Brazil. Survival curves were estimated using the Kaplan-Meier method, Cox regression, and conditional decision tree. Results. Women with triple-negative molecular subtypes had a shorter survival time compared to women with positive hormone receptors. The addition of hormone therapy reduced the risk of a patient dying by 5.5%, and the risk of a HER2-positive patient dying was 34.5% lower compared to those who were negative for this gene. Patients undergoing hormone therapy had a median survival time of 4 753 days. Conclusions. This paper shows a favorable scenario for the use of immunotherapy for patients with HER2 overexpression. Further studies could assess the effectiveness of immunotherapy in patients with other conditions, to favor the prognosis and better quality of life for the patient. [ABSTRACT FROM AUTHOR]

Keywords: Cancer; Diagnostics and Screening; Food Science; Health and Medicine; Oncology; University of Massachusetts Amherst EN Cancer Diagnostics and Screening Food Science Health and Medicine Oncology University of Massachusetts Amherst 135 135 1 06/05/23 20230608 NES 230608 2023 JUN 6 (NewsRx) -- By a News Reporter-Staff News Editor at Food Weekly News -- AMHERST, Mass. - While an overwhelming majority of cancer patients experience taste disruption from their disease or treatment, they have consistently reported a lack of support from their doctors about this troubling side effect, according to research. "We were testing their knowledge about taste, and we also wanted to learn about their experiences with educational materials and their perspective on taste alterations in cancer patients.". [Extracted from the article]

Keywords: Cancer; Colon Cancer; Colorectal Research; Gastroenterology; Health and Medicine; Oncology; Quality of Life EN Cancer Colon Cancer Colorectal Research Gastroenterology Health and Medicine Oncology Quality of Life 1144 1144 1 05/22/23 20230523 NES 230523 2023 MAY 23 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- New research on colon cancer is the subject of a new report. Cancer, Colon Cancer, Colorectal Research, Gastroenterology, Health and Medicine, Oncology, Quality of Life The primary outcome of interest was the global quality of life in patients with early-onset colorectal cancer. [Extracted from the article]

Keywords: Cancer; Cancer Risk; Drugs and Therapies; Genetics; Health and Medicine; Oncology; Personalized Medicine; Personalized Therapy; Risk and Prevention; The Wistar Institute EN Cancer Cancer Risk Drugs and Therapies Genetics Health and Medicine Oncology Personalized Medicine Personalized Therapy Risk and Prevention The Wistar Institute 2023 FEB 20 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Vaccine Week -- PHILADELPHIA - (FEBRUARY, 6, 2023) - In a paper published in PNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ronald Caplan Cancer Center and Ira Brind Professor and Program Leader in the Molecular & Cellular Oncogenesis Program, and team have identified a gene signature that accurately predicts the functioning of P53 variants, important information to assessing cancer risk and optimizing choices for cancer therapeutics. Cancer, Drugs and Therapies, Genetics, Health and Medicine, Oncology, Personalized Medicine, Personalized Therapy, Risk and Prevention, The Wistar Institute, Cancer Risk. [Extracted from the article]

A recent report from the University of Cambridge discusses the unique communication needs of teenagers and young adults with cancer (TYACs). The study aimed to understand who is present during healthcare consultations with TYACs, their experiences of communication with a supporter present, and the impact of this supporter on communication. The review found that mothers were the most common supporter present in clinical communication encounters, and TYACs' experiences of triadic communication were paradoxical. The study concludes that healthcare professionals need further training on effective triadic communication with TYACs. [Extracted from the article]

A systematic review conducted by researchers at University Teknologi MARA aimed to determine the prevalence and measurements of financial toxicity (FT) among colorectal cancer (CRC) patients. The review found that there is a lack of consensus in defining and quantifying financial toxicity, which hinders the comparability of results. Additionally, the majority of studies included in the review were from high-income countries, with none from low-income countries, limiting the global representativeness of the findings. The researchers emphasize the need for more information from low-income countries and a standardized approach to measuring financial toxicity in order to better understand the cost of managing CRC. [Extracted from the article]

A new report on breast cancer research discusses the increasing prevalence of breast cancer among older adults in Canada. The report highlights the unique challenges faced by this patient population, including distinct biological, psychosocial, and treatment-related considerations. The research aims to provide evidence-based recommendations and practical guidance for healthcare professionals involved in the care of older adults with breast cancer, with the goal of optimizing treatment outcomes and improving the overall quality of care for this population. The report can be accessed for free online and includes contributions from multiple authors. [Extracted from the article]

RAISE (Resources and Assistance to Support Empowerment) is a registry-style program developed by the Tigerlily Foundation and WiTT Forever to help individuals with cancer overcome barriers to care. The platform aims to empower patients by bridging the gap between their needs and the opportunity to have a better quality of life during treatment or clinical trials. RAISE allows patients to articulate their needs, from financial assistance to emotional support, and provides a safe and trusted place to capture everything they need in real-time. The program addresses health equity by recognizing the disparities in health outcomes experienced by marginalized communities and creating a virtual community that transcends traditional barriers. Patients can create a registry-style list of their needs and share it with their personal community, who can then provide direct support through the platform. RAISE is a lifeline and a testament to the transformative power of community and compassion in overcoming obstacles to equal health. [Extracted from the article]

Transcendent experiences, when our sense of self takes a back seat, seem to be good for us – and there is no need to go to extremes to get the benefits, finds Jess Craig [ABSTRACT FROM AUTHOR]

A report from the University of Texas Medical Branch discusses the imaging findings in a patient with advanced prostate cancer and bone metastases. The initial whole-body bone scan showed extensive disease, but the patient responded well to treatment and showed clinical improvement in follow-up. However, serial follow-up bone scans showed normalization after about 18 months. The report aims to discuss the limitations of bone scintigraphy in evaluating treatment responses in patients with prostate cancer. For more information, the full article can be accessed through the provided link. [Extracted from the article]

Keywords: Breast Cancer; Cancer; Health and Medicine; Oncology; Psychological; Psychosocial; Women's Health EN Breast Cancer Cancer Health and Medicine Oncology Psychological Psychosocial Women's Health 334 334 1 11/06/23 20231107 NES 231107 2023 NOV 7 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Oncology Week -- A new study on breast cancer is now available. Breast Cancer, Cancer, Health and Medicine, Oncology, Psychological, Psychosocial, Women's Health. [Extracted from the article]

The practitioner-led and system-led factors such as trivialisation of symptoms by general practitioners, non cancer-specific referrals, and lack of cancer screening facilities accounted for a major part of delay after the formal help seeking. Keywords: Bengaluru; India; Asia; Cancer; Cancer Prevention; Diagnostics and Screening; Gender Health; Gender and Health; Health and Medicine; Oncology; Risk and Prevention; Women's Health EN Bengaluru India Asia Cancer Cancer Prevention Diagnostics and Screening Gender Health Gender and Health Health and Medicine Oncology Risk and Prevention Women's Health 204 204 1 10/09/23 20231009 NES 231009 2023 OCT 9 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Vaccine Week -- New research on Cancer is the subject of a report. [Extracted from the article]

For more information on this research see: Vaginal mucositis in patients with gynaecological cancer undergoing (chemo-)radiotherapy: a retrospective analysis. Keywords: Cancer; Digestive System Diseases and Conditions; Drugs and Therapies; Gynecology; Health and Medicine; Mucositis; Oncology; Radiotherapy; Women's Health EN Cancer Digestive System Diseases and Conditions Drugs and Therapies Gynecology Health and Medicine Mucositis Oncology Radiotherapy Women's Health 539 539 1 10/03/23 20231006 NES 231006 2023 OCT 3 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Data detailed on mucositis have been presented. [Extracted from the article]

Keywords: Cancer; Cyborgs; Drugs and Therapies; Emerging Technologies; Genetics; Health and Medicine; Machine Learning; Massachusetts Institute of Technology; Oncology; Personalized Medicine; Personalized Therapy; Technology EN Cancer Cyborgs Drugs and Therapies Emerging Technologies Genetics Health and Medicine Machine Learning Massachusetts Institute of Technology Oncology Personalized Medicine Personalized Therapy Technology 101 101 1 08/21/23 20230822 NES 230822 2023 AUG 22 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- CAMBRIDGE, MA -- For a small percentage of cancer patients, doctors are unable to determine where their cancer originated. Among those patients, those who received a treatment consistent with the type of cancer that the model predicted for them fared better than patients who received a treatment typically given for a different type of cancer than what the model predicted for them. These targeted treatments tend to be more effective and have fewer side effects than treatments that are used for a broad spectrum of cancers, which are commonly prescribed to CUP patients. [Extracted from the article]

Keywords: Breast Cancer; Cancer; Epidemiology; Genetics; Health and Medicine; Mass General Brigham; Oncology; Women's Health EN Breast Cancer Cancer Epidemiology Genetics Health and Medicine Mass General Brigham Oncology Women's Health 1123 1123 1 08/07/23 20230808 NES 230808 2023 AUG 8 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Brigham researchers and international collaborators identified the association with younger age and advanced stage at diagnosis, coupled with the trauma associated with displacement, as likely contributors to the disparities. Breast Cancer, Cancer, Epidemiology, Genetics, Health and Medicine, Mass General Brigham, Oncology, Women's Health. [Extracted from the article]

The author relates how she revised her graphic memoir which she called "Cancer Confidential" into "Why Is Everybody Yelling?: Growing Up in My Immigrant Family." She discusses how she coped up when she was diagnosed with a cancer, her idea formed that if she expressed her feelings about the nightmare of cancer in a graphic memoir, she would be able to heal herself emotionally, and the encouragement she received from editor Mark Siegel to pursue her plan for her book.

Carol McGiffin, former panelist on the ITV daytime show Loose Women, has opened up about her new life in France and her feelings about leaving the show. While she enjoys the French way of life, she does sometimes miss appearing on Loose Women. However, she has mixed feelings about the show, finding it "woke" and not wanting to be on a show that panders to that. Despite leaving the show, Carol remains friends with some of her former co-stars. She also commented on Ruth Langsford's recent split from her husband Eamonn Holmes, expressing sympathy for them. Carol and her husband Mark Cassidy, who have a 22-year age gap, are considering renewing their vows. Carol is currently focused on writing her second memoir, which will cover her life from 2010 to the present day. [Extracted from the article]

Keywords: Brain Cancer; Brain Diseases and Conditions; Brain Metastasis; Breast Cancer; Cancer; Clinical Research; Clinical Trials and Studies; Drugs and Therapies; Health and Medicine; Immunologic Agents; Immunotherapy; Mass General Brigham; Monoclonal Antibodies; Oncology; Pembrolizumab Therapy; Pharmaceuticals; Women's Health EN Brain Cancer Brain Diseases and Conditions Brain Metastasis Breast Cancer Cancer Clinical Research Clinical Trials and Studies Drugs and Therapies Health and Medicine Immunologic Agents Immunotherapy Mass General Brigham Monoclonal Antibodies Oncology Pembrolizumab Therapy Pharmaceuticals Women's Health 419 419 1 06/19/23 20230620 NES 230620 2023 JUN 20 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- In a phase 2 clinical trial of the immune checkpoint inhibitor pembrolizumab, investigators found that 42 percent of patients with metastatic brain cancer benefited from the therapy, with seven patients in the trial surviving longer than two years. Seven patients in the study experienced prolonged overall survival of two or more years, including five patients with primary breast cancer, one patient with primary melanoma and one patient with primary sarcoma. [Extracted from the article]

"An accurate predictive test would identify those patients that require close monitoring for any toxicities; when these might occur, therapy doses could be modified or paused as needed", she said, adding that it could also impact the inclusion of chemo with primary ICI therapy for some patients. Keywords: Adverse Drug Reactions; Antibodies; Biomarkers; Blood Proteins; Business; Calviri Inc.; Cancer; Diagnostics and Screening; Drugs and Therapies; Health and Medicine; Immunoglobulins; Immunology; Immunotherapy; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Oncology; Proteins; Therapy EN Adverse Drug Reactions Antibodies Biomarkers Blood Proteins Business Calviri Inc. Cancer Diagnostics and Screening Drugs and Therapies Health and Medicine Immunoglobulins Immunology Immunotherapy Lung Cancer Lung Diseases and Conditions Lung Neoplasms Oncology Proteins Therapy 28 28 1 06/05/23 20230608 NES 230608 2023 JUN 5 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Vaccine Week -- Scientists studying immune checkpoint inhibitor (ICI) therapies in advanced lung cancer patients have found that a new class of blood-based biomarkers- anti-frameshift peptide antibodies, or anti-FSP antibodies- could be developed into improved or orthogonal tests for predicting tumor responses to treatment. [Extracted from the article]

Keywords: Thessaloniki; Greece; Europe; Cancer; Health and Medicine; Oncology EN Thessaloniki Greece Europe Cancer Health and Medicine Oncology 394 394 1 05/02/23 20230502 NES 230502 2023 MAY 2 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Cancer. Thessaloniki, Greece, Europe, Cancer, Health and Medicine, Oncology Keywords for this news article include: Thessaloniki, Greece, Europe, Cancer, Health and Medicine, Oncology, Aristotle University of Thessaloniki. [Extracted from the article]

Findings in this study demonstrated that narrative therapy treatment effectively relieved oral cancer patients' sense of shame, reducing overall stigma and significantly improving self-esteem and social relationships. Keywords: Jinan; People's Republic of China; Asia; Cancer; Clinical Research; Clinical Trials and Studies; Health and Medicine; Mouth Neoplasms; Oncology; Oral Cancer; Psychological EN Jinan People's Republic of China Asia Cancer Clinical Research Clinical Trials and Studies Health and Medicine Mouth Neoplasms Oncology Oral Cancer Psychological 162 162 1 04/24/23 20230424 NES 230424 2023 APR 25 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Data detailed on Oncology - Oral Cancer have been presented. [Extracted from the article]

Keywords: Olomouc; Czech Republic; Europe; Breast Cancer; Cancer; Health and Medicine; Hemic and Immune Systems; Immunology; Lymph Nodes; Lymphoid Tissue; Oncology; Women's Health EN Olomouc Czech Republic Europe Breast Cancer Cancer Health and Medicine Hemic and Immune Systems Immunology Lymph Nodes Lymphoid Tissue Oncology Women's Health 535 535 1 04/17/23 20230418 NES 230418 2023 APR 18 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Fresh data on Oncology - Breast Cancer are presented in a new report. Lymph node metastases were detected in 145 cases, while in the remaining 40 cases benign changes or normal lymph node (LN) histology was observed. [Extracted from the article]